MIR-133A IS A PREDICTIVE BIOMARKER IN PATIENTS WITH METASTATIC COLORECTAL CANCER RECEIVING OXALIPLATIN-BASED CHEMOTHERAPY

被引：0
|
作者：
Ng, Simon S.
Dong, Yujuan
Leung, Wing Wa
Ma, Brigette B.
To, Ka Fai
Sung, Joseph J.
Yu, Jun
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
374
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [21] Role of Calcium/Magnesium Infusion in Oxaliplatin-Based Chemotherapy for Colorectal Cancer Patients
    Kurniali, Peter C.
    Luo, Lu Guang
    Weitberg, Alan B.
    ONCOLOGY-NEW YORK, 2010, 24 (03): : 289 - 292
  • [22] Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    L Paré-Brunet
    A Sebio
    J Salazar
    A Berenguer-Llergo
    E Río
    A Barnadas
    M Baiget
    D Páez
    The Pharmacogenomics Journal, 2015, 15 : 397 - 404
  • [23] Genetic variations in the VEGF pathway as prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy
    Pare-Brunet, L.
    Sebio, A.
    Salazar, J.
    Berenguer-Llergo, A.
    Rio, E.
    Barnadas, A.
    Baiget, M.
    Paez, D.
    PHARMACOGENOMICS JOURNAL, 2015, 15 (05): : 397 - 404
  • [24] MACC1 expression as a candidate prognostic biomarker in colorectal cancer patients receiving adjuvant oxaliplatin-based therapy
    Symonds, Lynn Katherine
    Baker, Kelsey K.
    Redman, Mary Weber
    Koch, Lisa
    Carter, Kelly
    Yu, Ming
    Wirtz, Ralph
    Poulios, Christos
    Pentheroudakis, George E.
    Papaxoinis, George
    Pectasides, Dimitrios G.
    Kalogeras, Konstantine T.
    Fountzilas, George
    Grady, William M.
    Cohen, Stacey
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [25] Efficacy and Safety of Oxaliplatin-based Regimens as First-line Chemotherapy in Elderly Patients With Metastatic Colorectal Cancer
    Yamamoto, Seiji
    Fujii, Hironori
    Murayama, Kotaro
    Iihara, Hirotoshi
    Watanabe, Daichi
    Yamada, Yunami
    Kobayashi, Ryo
    Kiyama, Shigeru
    Makiyama, Akitaka
    Urano, Kimihiko
    Matsuhashi, Nobuhisa
    Matsuura, Katsuhiko
    Suzuki, Akio
    ANTICANCER RESEARCH, 2023, 43 (11) : 5099 - 5105
  • [26] CA19-9 level as a prognostic and predictive factor of bevacizumab efficacy in metastatic colorectal cancer patients undergoing oxaliplatin-based chemotherapy
    Narita, Yukiya
    Taniguchi, Hiroya
    Komori, Azusa
    Nitta, Sohei
    Yamaguchi, Kazuhisa
    Kondo, Chihiro
    Nomura, Motoo
    Kadowaki, Shigenori
    Takahari, Daisuke
    Ura, Takashi
    Andoh, Masashi
    Muro, Kei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (02) : 409 - 416
  • [27] CA19-9 level as a prognostic and predictive factor of bevacizumab efficacy in metastatic colorectal cancer patients undergoing oxaliplatin-based chemotherapy
    Yukiya Narita
    Hiroya Taniguchi
    Azusa Komori
    Sohei Nitta
    Kazuhisa Yamaguchi
    Chihiro Kondo
    Motoo Nomura
    Shigenori Kadowaki
    Daisuke Takahari
    Takashi Ura
    Masashi Andoh
    Kei Muro
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 409 - 416
  • [28] Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (03) : 319 - 329
  • [29] Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy for metastatic colorectal cancer.
    Rubbia-Brandt, L
    Audard, V
    Sartoretti, P
    Roth, AD
    Brezault, C
    Lecharpentier, M
    Dousset, B
    Morel, P
    Soubrane, O
    Chaussade, S
    Mentha, G
    Terris, B
    HEPATOLOGY, 2003, 38 (04) : 696A - 696A
  • [30] TWIST1 Polymorphisms Predict Survival in Patients with Metastatic Colorectal Cancer Receiving First-Line Bevacizumab plus Oxaliplatin-Based Chemotherapy
    Matsusaka, Satoshi
    Zhang, Wu
    Cao, Shu
    Hanna, Diana L.
    Sunakawa, Yu
    Sebio, Ana
    Ueno, Masashi
    Yang, Dongyun
    Ning, Yan
    Parekh, Anish
    Okazaki, Satoshi
    Berger, Martin D.
    Ichikawa, Wataru
    Mizunuma, Nobuyuki
    Lenz, Heinz-Josef
    MOLECULAR CANCER THERAPEUTICS, 2016, 15 (06) : 1405 - 1411
12345